Provigil (Modafinil) is a drug classified as a “eugeroic” or wakefulness promoting agent. It is considered one of the most effective medications in treating shift work sleep disorder, narcolepsy, and excessive daytime sleepiness as a result of sleep apnea. Many people have also used this medication on an off-label basis for the treatment of depression, …
Topamax (Topiramate) is an anticonvulsant medication that is primarily used for the treatment of epilepsy, but has also been approved for migraine prevention and as an adjunct to phentermine for weight loss. It is also commonly used as an off-label medication to treat bipolar disorder as well as borderline personality disorder, but there is no …
As of February 2015, the FDA approved the psychostimulant Vyvanse (Lisdexamfetamine) for the treatment of binge eating disorder. In recent years, the popularity of Vyvanse has skyrocketed as an ADHD medication, as well as among those seeking to use it for ulterior purposes such as weight loss, academics, and sports performance. Many consider the medication …
Geodon (Ziprasidone) is an atypical antipsychotic that was approved by the FDA in 2001 for the treatment of schizophrenia. It has since been approved to manage both manic and mixed states of bipolar disorder. In some cases, the drug is used as an antidepressant augmentation strategy for the treatment of refractory depression, as well as …
Seroquel (Quetiapine) is a popular atypical antipsychotic medication that has been approved by the FDA to treat schizophrenia, bipolar disorder, and as an antidepressant augmentation strategy in cases of refractory depression. Due to the variety of conditions for which this drug is prescribed, it is considered highly profitable and has made AstraZeneca (the developers) billions …
Viibryd (Vilazodone) is a drug that was developed by Merck for the treatment of clinical depression. It was approved in the United States as an antidepressant medication in 2011. It functions as an atypical serotonergic antidepressant. Although some consider it to be similar to SSRIs, it differs in that it is unlikely to cause significant …
Pristiq (Desvenlafaxine) is a drug that was approved for the treatment of major depression in 2007. It functions as an SNRI (serotonin-norepinephrine reuptake inhibitor) and increases extracellular levels of two neurotransmitters. In addition to treating depression, it is also being investigated as a non-hormonal approach to treating menopause. This drug is considered very similar to …